Speaking at a conference organized by the Association for Accessible Medicines, an FDA official said the Trump administration’s restrictions on hiring foreign scientists are making it more difficult for the agency to attract top scientific talent; HHS Secretary Alex Azar met with Republican lawmakers on the House Ways and Means Committee to discuss ways to lower drug prices; previously secret emails from Judge Brett Kavanaugh’s time working for President George W. Bush provoked new scrutiny during his Supreme Court confirmation hearing regarding his views on abortion and other women’s health issues.
Speaking at a conference organized by the Association for Accessible Medicines, the generic drug industry’s trade group, an FDA official said the Trump administration’s restrictions on hiring foreign scientists are making it more difficult for the agency to attract top scientific talent, STAT reported. Melanie Keller, the FDA’s acting associate commissioner for scientific and clinical recruitment, was referring to a Department of Homeland Security policy the agency has been implementing since at least last August, which requires the agency to restrict many of its employment offers to people who have lived in the United States for 3 of the past 5 years.
HHS Secretary Alex Azar met with Republican lawmakers on the House Ways and Means Committee to discuss ways to lower drug prices, The Hill reported, although specifics of possible actions that might be taken were not disclosed. Lawmakers discussed rebates with Azar, according to Representative Tom Reed of New York, and House Ways and Means Chairman Kevin Brady of Texas said he expects the administration to announce actions in the near future.
Previously secret emails from Judge Brett Kavanaugh’s time working for President George W. Bush provoked new scrutiny during his Supreme Court confirmation hearing regarding his views on abortion and other women’s health issues, The New York Times reported. Kavanaugh previously said he considered Roe v Wade settled precedent, but in a disclosed 2003 email, he wrote: “I am not sure that all legal scholars refer to Roe as the settled law of the land at the Supreme Court level since Court can always overrule its precedent, and three current Justices on the Court would do so.” In another email, he described contraceptives as “abortion-inducing drugs.”
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More